Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Department of Health and Human Services (HHS)
Research
NIH chief orders immediate research review, threatens cuts
Current and proposed projects, external and internal, that don't align with NIH priorities "may be restricted, paused, not renewed or terminated."
Darren Incorvaia
Aug 15, 2025 3:53pm
Fierce Pharma
HHS, NIH, CDC leaders to steer revived vaccine safety panel
Aug 14, 2025 3:52pm
ARPA-H data chief departs over mRNA vax cancellations
Aug 12, 2025 12:15pm
Vaxart seeks answers as BARDA vaccine funding dries up again
Aug 12, 2025 5:08am
Fierce Pharma
Vinay Prasad is back at the FDA after last month's surprise ouster
Aug 9, 2025 12:22pm
Federal mRNA vax grant cuts includes unrelated project
Aug 7, 2025 2:20pm
